Historical record - last NADAC publication: 2/22/2023
Product Information
CONTRAVE ER 8-90 MG TABLET is a brand product labeled by Nalpropion Pharmaceuticals LLC, priced at $4.9810 per EA under NDC 51267089099. Its NADAC has been published 340 times since Mar 29, 2017.
Strength
90; 8 mg/1; mg/1
Manufacturer
Nalpropion Pharmaceuticals LLCNDC
51267089099
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
2/22/2023
Active Ingredients
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA200063On Market Since
10/22/2014
Pharmacological Classes
Price Statistics
The NADAC for CONTRAVE ER 8-90 MG TABLET has been published 340 times since Mar 29, 2017, and over the history we have for it it has risen 181.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9810 per EA |
|---|---|
| All-time high | $4.9877 (Feb 15, 2023) |
| All-time low | $1.7704 (Mar 29, 2017) |
| Median price | $2.2293 |
| Average price | $2.8714 |
| Largest weekly change | +105.9% (Mar 9, 2022) |
| Weeks tracked | 340 |
| Tracking since | Mar 29, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the naltrexone hydrochloride and bupropion hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CONTRAVE ER 8-90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CONTRAVE ER 8-90 MG TABLET, manufactured by Nalpropion Pharmaceuticals LLC, is $4.9810 per EA (NDC 51267089099), effective Sep 27, 2023.
How has the price of CONTRAVE ER 8-90 MG TABLET changed over time?
Over the history we have for it, the NADAC for CONTRAVE ER 8-90 MG TABLET has risen 181.3%. It has been tracked across 340 weekly CMS publications since Mar 29, 2017.
What are the highest and lowest recorded NADAC prices for CONTRAVE ER 8-90 MG TABLET?
Since Mar 29, 2017, the NADAC for CONTRAVE ER 8-90 MG TABLET has ranged from a low of $1.7704 (Mar 29, 2017) to a high of $4.9877 (Feb 15, 2023), with a median of $2.2293 per EA.
Are there cheaper alternatives to CONTRAVE ER 8-90 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CONTRAVE ER 8-90 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CONTRAVE ER 8-90 MG TABLET?
CONTRAVE ER 8-90 MG TABLET (NDC 51267089099) is labeled by Nalpropion Pharmaceuticals LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification